As of January 22, 2025, MDxHealth (MDXH) has a market cap of $99.490 million USD. According to our data, MDxHealth is ranked No.7694 in global market value.
Year | Market Cap | %Change |
---|---|---|
Jan 22, 2025 | $99.49 M |
-15.19%
|
Dec 31, 2024 | $0.12 B |
-39.85%
|
Dec 29, 2023 | $0.20 B |
-40.39%
|
Dec 30, 2022 | $0.33 B |
-30.57%
|
Dec 31, 2021 | $0.47 B |
100%
|
Name | Market Cap | Market cap difference | Regions |
---|---|---|---|
Exact Sciences
EXAS
|
$10.14 B |
0.000 M
|
USA
|
Myriad Genetics
MYGN
|
$1.12 B |
-0.000 M
|
USA
|
Veracyte
VCYT
|
$3.34 B |
-0.000 M
|
USA
|
Natera
NTRA
|
$22.70 B |
-0.001 M
|
USA
|
Guardant Health
GH
|
$5.83 B |
0.000 M
|
USA
|
NeoGenomics
NEO
|
$1.86 B |
0.000 M
|
USA
|
Fulgent Genetics
FLGT
|
$0.52 B |
-0.000 M
|
USA
|
Adaptive Biotechnologies
ADPT
|
$1.18 B |
0.000 M
|
USA
|
Personalis
PSNL
|
$0.47 B |
0.000 M
|
USA
|
CareDx
CDNA
|
$1.24 B |
-0.000 M
|
USA
|
OncoCyte
OCX
|
$33.00 M |
0.000 M
|
USA
|
Market Cap | = | MDXH Stock Price | * | MDXH Shares Outstanding |
= | $2.01 | * | 49.50 M | |
= | $99.49 M |